BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 15630726)

  • 1. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
    Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
    Takada K; Nagasaka K; Miyasaka N
    Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
    J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement.
    Grau JM; Miró O; Pedrol E; Casademont J; Masanés F; Herrero C; Haussman G; Urbano-Márquez A
    J Rheumatol; 1996 Nov; 23(11):1921-6. PubMed ID: 8923367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia.
    Kourakata H; Takada T; Suzuki E; Enomoto K; Saito I; Taguchi Y; Tsukada H; Nakano M; Arakawa M
    Respirology; 1999 Sep; 4(3):223-8. PubMed ID: 10489663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
    PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyositis-dermatomyositis-associated interstitial lung disease.
    Douglas WW; Tazelaar HD; Hartman TE; Hartman RP; Decker PA; Schroeder DR; Ryu JH
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1182-5. PubMed ID: 11673206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
    Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
    Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
    Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
    Schnabel A; Reuter M; Biederer J; Richter C; Gross WL
    Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
    Fujita J; Dobashi N; Tokuda M; Bandoh S; Ohtsuki Y; Yamadori I; Yoshinouchi T; Ueda Y; Takahara J
    J Rheumatol; 1999 Nov; 26(11):2377-82. PubMed ID: 10555895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.